Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 CNS 1

Conditions

Carcinoma, Hepatocellular 28 Carcinoma, Non-Small-Cell Lung 23 Lung Neoplasms 17 Biliary Tract Neoplasms 13 Small Cell Lung Carcinoma 12 Cholangiocarcinoma 12 Triple Negative Breast Neoplasms 8 Breast Neoplasms 8 Neoplasms 6 Neoplasm Metastasis 5 Liver Neoplasms 5 Urinary Bladder Neoplasms 4 Stomach Neoplasms 4 Carcinoma 4 Pancreatic Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Gallbladder Neoplasms 3 Colorectal Neoplasms 3 Adenocarcinoma Of Esophagus 3 Pathologic Complete Response 2 Ovarian Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Bile Duct Neoplasms 2 Advanced Biliary Tract Cancer 2 Adenocarcinoma of Lung 2 Adenocarcinoma 2 Vaccinia 1 SCLC, Limited Stage 1 Resectable Intrahepatic Cholangiocarcinoma 1

Interventions

Magnetic Resonance Spectroscopy 19 Temozolomide 16 Radiotherapy 10 Specimen Handling 7 Blood Specimen Collection 7 Radiation 6 Bevacizumab 5 Nivolumab 4 Cyclophosphamide 4 Biopsy 4 vorasidenib 3 trametinib 3 pembrolizumab 3 olaparib 3 fludarabine 3 dabrafenib 3 Watchful Waiting 3 Surgical Procedures, Operative 3 Magnetic Resonance Imaging 3 Drug Therapy 3 olutasidenib 2 lutetium Lu 177 dotatate 2 fluorodopa F 18 2 fluciclovine F-18 2 entrectinib 2 contrast agent BR1 2 Restraint, Physical 2 Radiosurgery 2 Microdialysis 2 Flucytosine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Glioma × durvalumab × Clear all

NCT03991832 2024-07-18

SOLID

University Health Network, Toronto

Phase 2 Recruiting

CNSGastrointestinal

Glioma, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡